Press Release

Orchid Pharma Limited has entered into a licensing and supply agreement with Pharmasyntez JSC, Russia, for the commercialization of Exblifep (Cefepime/Enmetazobactam) in Russia, a novel combination antibiotic for the treatment of complicated urinary tract infections and hospital-acquired and ventilator-associated bacterial pneumonia.